Radiotherapy and androgen ablation for clinically localized high-risk prostate cancer
- 30 April 1995
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 32 (1) , 13-20
- https://doi.org/10.1016/0360-3016(94)00450-y
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prostate Specific Antigen after External Beam Radiotherapy for Prostatic Cancer: FollowupJournal of Urology, 1993
- Heterogeneity in the Development of Apoptosis in Irradiated Murine Tumours of Different HistologiesInternational Journal of Radiation Biology, 1993
- Hormonal Treatment at Time of Radical Retropubic Prostatectomy for Stage D1 Prostate Cancer: Results of Long-Term FollowupJournal of Urology, 1992
- Histologic grading of prostate cancer: A perspectiveHuman Pathology, 1992
- The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: The radiation therapy oncology group 75-06 and 77-06 experienceInternational Journal of Radiation Oncology*Biology*Physics, 1991
- The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Prognosis of Patients with Stage D1 Prostate Carcinoma Following Radical Prostatectomy with and Without Early Endocrine TherapyJournal of Urology, 1990
- Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castrationThe Prostate, 1989
- The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancerThe Prostate, 1984
- Histologic grading study of prostate adenocarcinoma: The development of a new system and comparison with other methods—A preliminary studyCancer, 1982